Received Oct 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Frozen shoulder; nurse administered the vaccine too high into the shoulder joint, rather than into the deltoid muscle; This serious case was reported by a consumer via sales rep and described the occurrence of frozen shoulder in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced frozen shoulder (Verbatim: Frozen shoulder) (serious criteria other: Serious as per reporter) and vaccine administered at inappropriate site (Verbatim: nurse administered the vaccine too high into the shoulder joint, rather than into the deltoid muscle). The outcome of the frozen shoulder was resolved and the outcome of the vaccine administered at inappropriate site was not applicable. The reporter considered the frozen shoulder to be unrelated to Shingrix. The company considered the frozen shoulder to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 07-OCT-2025 The reporter stated that they themselves were the patient, and the nurse administered the vaccine too high into the shoulder joint, rather than into the deltoid muscle. The reporter stated that the event had nothing to do with the product itself, but rather the incorrect administration technique. No other products were received by the patient. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Periarthritis, an unknown time after receiving Shingrix, in an adult female patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.